Moreover, it has recently been reported that RCC patients who have mutations in the TP53 gene and in the SMARCA4 (BRG1) gene, which is part of the SWI/SNF remodeling complex, have a poor prognosis [64,65]. This evidence concerns the gene SMARCA4 and renal cell carcinoma.